Mast Therapeutics Revenue 2006-2019 | SVRA

Mast Therapeutics revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Mast Therapeutics Annual Revenue
(Millions of US $)
2018 $
2017 $
2016 $0
2015 $0
2014 $
2013 $
2012 $
2011 $
2010 $0
2009 $0
2008 $
2007 $1
2006 $
2005 $
Mast Therapeutics Quarterly Revenue
(Millions of US $)
Q1 2019
Q4 2018
Q3 2018
Q2 2018
Q1 2018
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q1 2013
Q4 2012
Q3 2012
Q2 2012
Q1 2012
Q4 2011
Q3 2011
Q2 2011
Q1 2011
Q4 2010
Q3 2010
Q2 2010
Q1 2010
Q4 2009
Q3 2009
Q2 2009
Q1 2009 $0
Q4 2008
Q3 2008
Q2 2008 $1
Q1 2008
Q4 2007
Q3 2007
Q2 2007
Q1 2007 $1
Q4 2006
Q3 2006
Q2 2006
Q1 2006
Q4 2005
Q3 2005
Q2 2005
Q1 2005
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.096B $0.000B
Savara Inc. is a clinical-stage pharmaceutical company. It focused on the development and commercialization of novel therapies for the treatment of patients with rare respiratory diseases. Savara Inc., formerly known as Mast Therapeutics, Inc., is based in Austin, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.530B 37.28
Astellas Pharma (ALPMY) Japan $26.750B 13.12
Takeda Pharmaceutical (TAK) Japan $26.248B 8.20
Grifols, S.A (GRFS) Spain $15.195B 19.39
UCB SA (UCBJF) Belgium $15.008B 0.00
Eisai (ESALY) Japan $14.512B 24.95
Merck (MKGAF) Germany $13.654B 18.63
Ionis Pharmaceuticals (IONS) United States $9.835B 21.21
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $9.041B 0.00
IPSEN SA ADR (IPSEY) France $8.570B 0.00
Sage Therapeutics (SAGE) United States $8.490B 0.00
Catalent (CTLT) United States $8.196B 32.90
Jazz Pharmaceuticals (JAZZ) Ireland $7.686B 10.11
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.894B 17.59
FibroGen (FGEN) United States $3.948B 98.74
United Therapeutics (UTHR) United States $3.588B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.197B 73.30
Taro Pharmaceutical Industries (TARO) Israel $3.174B 11.38
Nektar Therapeutics (NKTR) United States $3.132B 0.00
Evotec AG (EVTCY) Germany $3.127B 42.81
Tilray (TLRY) Canada $2.910B 0.00
PTC Therapeutics (PTCT) United States $2.741B 0.00
Xencor (XNCR) United States $2.298B 50.10
Zogenix (ZGNX) United States $2.161B 0.00
Portola Pharmaceuticals (PTLA) United States $2.046B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.578B 57.42
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.516B 15.20
Corcept Therapeutics (CORT) United States $1.490B 20.48
Enanta Pharmaceuticals (ENTA) United States $1.421B 23.44
Heron Therapeutics (HRTX) United States $1.417B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.405B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.207B 0.00
Aerie Pharmaceuticals (AERI) United States $1.097B 0.00
ArQule (ARQL) United States $1.074B 0.00
Radius Health (RDUS) United States $1.063B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.933B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.855B 3.81
TherapeuticsMD (TXMD) United States $0.680B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.616B 0.00
Endo (ENDP) Ireland $0.577B 1.02
Akebia Therapeutics (AKBA) United States $0.574B 0.00
Karyopharm Therapeutics (KPTI) United States $0.572B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.545B 0.00
Concordia (CXRXF) Canada $0.533B 0.00
Indivior (INVVY) United States $0.520B 1.88
Aptorum Group (APM) China $0.467B 0.00
Dermira (DERM) United States $0.466B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.460B 0.00
Organogenesis Holdings (ORGO) United States $0.453B 0.00
Dova Pharmaceuticals (DOVA) United States $0.435B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.432B 19.67
ImmunoGen (IMGN) United States $0.427B 0.00
Flexion Therapeutics (FLXN) United States $0.418B 0.00
Translate Bio (TBIO) United States $0.415B 0.00
Siga Technologies (SIGA) United States $0.412B 0.96
ChemoCentryx (CCXI) United States $0.412B 0.00
Collegium Pharmaceutical (COLL) United States $0.389B 0.00
Innate Pharma SA (IPHYF) France $0.374B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.370B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.334B 0.00
Xeris Pharmaceuticals (XERS) United States $0.315B 0.00
CV Sciences (CVSI) United States $0.314B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.296B 0.00
KalVista Pharmaceuticals (KALV) United States $0.288B 0.00
CannTrust Holdings (CTST) Canada $0.286B 0.00
Harpoon Therapeutics (HARP) United States $0.285B 0.00
Rafael Holdings (RFL) United States $0.276B 0.00
Lannett Co Inc (LCI) United States $0.272B 2.64
La Jolla Pharmaceutical (LJPC) United States $0.270B 0.00
OptiNose (OPTN) United States $0.269B 0.00
DURECT (DRRX) United States $0.261B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.258B 0.00
Recro Pharma (REPH) United States $0.253B 0.00
Concert Pharmaceuticals (CNCE) United States $0.252B 0.00
Calithera Biosciences (CALA) United States $0.220B 0.00
Ocular Therapeutix (OCUL) United States $0.217B 0.00
Molecular Templates (MTEM) United States $0.188B 0.00
Ardelyx (ARDX) United States $0.187B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.185B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.183B 0.00
Nature's Sunshine Products (NATR) United States $0.176B 29.48
Taiwan Liposome (TLC) Taiwan $0.171B 0.00
Redhill Biopharma (RDHL) Israel $0.152B 0.00
IMV INC (IMV) Canada $0.151B 0.00
GlycoMimetics (GLYC) United States $0.151B 0.00
Generex Biotechnology (GNBT) United States $0.138B 0.00
Majesco Entertainment (PTE) United States $0.134B 0.00
Jounce Therapeutics (JNCE) United States $0.127B 0.00
MEI Pharma (MEIP) United States $0.125B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.125B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.121B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.111B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.110B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.104B 0.00
AgeX Therapeutics (AGE) United States $0.103B 0.00
Cardiome Pharma (CORV) Canada $0.101B 0.00
Iterum Therapeutics (ITRM) Ireland $0.096B 0.00
Neos Therapeutics (NEOS) United States $0.093B 0.00
Aquestive Therapeutics (AQST) United States $0.093B 0.00
Nivalis Therapeutics (ALPN) United States $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.083B 31.82
MediWound (MDWD) Israel $0.082B 0.00
Genocea Biosciences (GNCA) United States $0.081B 0.00
RENEURON GP (RNUGF) United Kingdom $0.080B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.076B 0.00
Natural Alternatives (NAII) United States $0.075B 7.52
China SXT Pharmaceuticals (SXTC) China $0.072B 0.00
Otonomy (OTIC) United States $0.072B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.068B 584.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Novan (NOVN) United States $0.065B 0.00
Capnia (SLNO) United States $0.061B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.061B 0.00
Pharmaxis (PXSLY) Australia $0.060B 0.00
SCYNEXIS (SCYX) United States $0.060B 0.00
Lipocine (LPCN) United States $0.059B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
ElectroCore (ECOR) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.043B 0.00
India Globalization Capital (IGC) United States $0.042B 0.00
CTI BioPharma (CTIC) United States $0.039B 0.00
Aclaris Therapeutics (ACRS) United States $0.038B 0.00
Melinta Therapeutics (MLNT) United States $0.037B 0.00
Bio-Path Holdings (BPTH) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
PharmAthene (ALT) United States $0.034B 0.00
Biomerica (BMRA) United States $0.030B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Opexa Therapeutics (ACER) United States $0.022B 0.00
IsoRay (ISR) United States $0.022B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 1.43
Tetraphase Pharmaceuticals (TTPH) United States $0.017B 0.00
Achieve Life Sciences (ACHV) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Onconova Therapeutics (ONTX) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.005B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00